Trial Profile
A Single Blind, Multicentric, Comparative, Vaccine Interchangeability Trial of Shan 5 (Liquid) and Easy Five (Liquid) [Diphtheria-Tetanus- Pertussis, Hepatitis B and Hib Pentavalent Combination Vaccines] in Indian Infants.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2009
Price :
$35
*
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Therapeutic Use
- Sponsors Shantha Biotechnics
- 26 Jun 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 26 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 Planned end date changed from 1 Dec 2008 to 1 Apr 2009 as reported by ClinicalTrials.gov.